CERRITOS, Calif.–(BUSINESS WIRE)–The Oncology Institute of Hope and Innovation (TOI) today launched a new website with enhanced search functionality and resources for patients, caregivers, referring physicians, health plans, and employment candidates.

ROBUST CLINICAL TRIAL DATABASE

TOI maintains one of the largest community-based clinical trial programs in the US. The new website enables users to search for cutting-edge clinical trials treating their disease.

IMPROVES ACCESSIBILITY

To better serve TOI’s diverse patient population, the website is offered in 5 different languages and is ADA compliant with features like text readers, magnifiers, and image descriptions.

ENABLES PATIENTS TO FIND A DOCTOR WHO SPEAKS THEIR LANGUAGE

TOI delivers high-quality cancer care to an extremely diverse population. To meet the needs of these communities, TOI clinicians speak more than 20 languages. The new website allows patients and caregivers to search for a provider who speaks their language and practices in their community.

MAKES SCHEDULING APPOINTMENTS ONLINE CONVENIENT

The website allows patients to conveniently request appointments online. Patients are also given the opportunity to complete and submit all forms online rather than filling them out in a clinic lobby.

Brad Hively, TOI’s CEO, states, “The mission of The Oncology Institute is to provide world-class cancer care close to home. Now, with our new website, we make access to the highest quality cancer information and care more convenient than ever before.”

About The Oncology Institute of Hope and Innovation

Founded in 2007, The Oncology Institute of Hope and Innovation (TOI) is one of the largest community oncology practices in the US as well as our nation’s leading value-based oncology services platform. TOI employs 75 physicians and mid-level practitioners in 42 clinic locations, with more than 500 total employees helping to offer leading-edge, evidence-based cancer care to a population of more than 1.5 million patients. TOI brings comprehensive, integrated cancer care into community settings, including clinical trials, palliative care programs, stem cell transplants, transfusions, and other care delivery models traditionally associated with the most advanced tertiary care settings. For more information visit www.theoncologyinstitute.com.